Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-25T14:10:30.694Z Has data issue: false hasContentIssue false

The discovery of critical illness polyneuropathy

Published online by Cambridge University Press:  01 February 2008

C. F. Bolton*
Affiliation:
Queen’s University, Department of Medicine, Canada
*
Correspondence to: Charles F. Bolton, Etherington Hall, Room 3008, 94 Stuart Street, Kingston, Ontario, CanadaK7L 3N6. E-mail: CB41@post.queensu.ca; Tel: +1 613 533 2865; Fax: +1 613 533 6695
Get access

Summary

In 1892 Osler described ‘rapid loss of flesh’ in prolonged sepsis. Thereafter, for years, limb weakness was attributed to cachectic myopathy, and difficulty weaning from mechanical ventilation was attributed to diaphragmatic fatigue. In 1961 Mertens described ‘coma-polyneuropathies’, and in 1971 Henderson and colleagues described polyneuropathy in patients with burns. In 1984 Bolton and colleagues, in a series of reports, defined the clinical, electrophysiological and morphological features of septic encephalopathy and critical illness polyneuropathy. Evidence suggested that polyneuropathy was due to the ‘toxic’ effects of sepsis. Polyneuropathy was a common cause of difficulty in weaning when lung and cardiac cause had been excluded. Since 1984, cases of critical illness polyneuropathy have been reported from several countries. Moreover, a number of investigators reported instances of critical illness myopathy. Comprehensive studies by Latronico and colleagues indicated that polyneuropathy and myopathy often occurred together in the same patient. With successful treatment of sepsis, improvement often occurred in encephalopathy, polyneuropathy and myopathy, except in very severe cases.

Type
Original Article
Copyright
Copyright © European Society of Anaesthesiology 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Osler, W. The Principles and Practice of Medicine. New York: D Appleton, 1892.Google Scholar
2.Mertens, HG. Disseminated neuropathy following coma. On the differentiation of so-called toxic polyneuropathy. Nervenarzt 1961; 32: 7179.Google Scholar
3.Henderson, B, Koepke, GH, Feller, I. Peripheral polyneuropathy among patients with burns. Arch Phys Med Rehabil 1971; 52: 149151.Google ScholarPubMed
4.Bolton, CF, Gilbert, JJ, Hahn, AF, Sibbald, WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984; 47: 12231231.Google ScholarPubMed
5.Zochodne, DW, Bolton, CF, Wells, GA et al. . Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987; 110: 819841.CrossRefGoogle ScholarPubMed
6.Witt, NJ, Zochodne, DW, Bolton, CF et al. . Peripheral nerve function in sepsis and multiple organ failure. Chest 1991; 99: 176184.CrossRefGoogle ScholarPubMed
7.Zifko, UA, Zipko, HT, Bolton, CF. Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 1998; 159: 186193.CrossRefGoogle ScholarPubMed
8.Young, GB, Bolton, CF, Austin, TW, Archibald, YM, Gonder, J, Wells, GA. The encephalopathy associated with septic illness. Clin Invest Med 1990; 13: 297304.Google ScholarPubMed
9.Bolton, CF, Young, GB, Zochodne, DW. The neurological complications of sepsis. Ann Neurol 1993; 33: 94100.Google Scholar
10.Maher, J, Rutledge, F, Remtulla, H, Parkes, A, Bernardi, L, Bolton, CF. Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 1995; 21: 737743.CrossRefGoogle ScholarPubMed
11.Bolton, CF. Neuromuscular manifestations of critical illness. Muscle Nerve 2005; 32: 140163.CrossRefGoogle ScholarPubMed
12.Zochodne, DW, Ramsay, DA, Saly, V, Shelley, S, Moffatt, S. Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994; 17: 285292.CrossRefGoogle ScholarPubMed
13.Lacomis, D, Zochodne, DW, Bird, SJ. Critical illness myopathy. Muscle Nerve 2000; 23: 17851788.Google Scholar
14.Latronico, N, Fenzi, F, Recupero, D et al. . Critical illness myopathy and neuropathy. Lancet 1996; 347: 15791582.Google Scholar
15.Fenzi, F, Latronico, N, Refatti, N, Rizzuto, N. Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol (Berl) 2003; 106: 7582.CrossRefGoogle ScholarPubMed
16.de Letter, MA, Schmitz, PI, Visser, LH et al. . Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001; 29: 22812286.CrossRefGoogle ScholarPubMed
17.van den Berghe, G, Wouters, P, Weekers, F et al. . Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 13591367.CrossRefGoogle ScholarPubMed